000			03225nam a22004215i 4500
999			_c119555 _d119555 _x1
001			119555
003			ES-MaUEC
005			20230102113955.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			200228s2020 gw | o |||| 0|eng d
020			_a9783030371739
024	7		_a10.1007/978-3-030-37173-9 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aQH438.4.B55 _b2020 EB
245	0	0	_aNAFLD and NASH . _bBiomarkers in Detection, Diagnosis and Monitoring _cedited by Manuel Romero-Gomez.
250			_aFirst edition 2020
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2020.
300			_a1 recurso en línea (X, 236 páginas) _b18 ilustraciones, 17 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aForeword -- Biochemical biomarkers of NAFLD/NASH -- MR based-Imaging Biomarkers in NAFLD/NASH -- Detection of NAFLD/NASH in general population -- Micro-vesicles in the diagnosis and monitoring of NASH -- Non-invasive biomarkers for monitoring NASH: NASH resolution and Fibrosis regression -- From transcriptome to proteomic in the development of biomarkers in NAFLD/NASH -- Transient elastography and ultrasound as imaging biomarkers in NAFLD/NASH -- Early detection of HCC in patients with NAFLD/NASH -- Genes and NAFLD/NASH progression -- Geometry of nutrition: micronutrients and NAFLD progression -- Psychological biomarkers profile in NAFLD/NASH with advanced fibrosis -- Integrative proposal of biomarkers use in clinical practice management of NAFLD/NASH.
520	3		_aThis book provides a comprehensive overview of the diagnosis and management of Non-alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatis (NASH). Basic principles of disease progression, the genetic and nutritional basis of NAFLD and NASH are explained along with the proteomic principles underlying biomarker development. Chapters cover both biochemical and imaging biomarkers used in elastrography and ultrasound and discuss how these are applicable to early diagnosis and monitoring of NASH and NAFLD. This is a useful resource for hepatologists, primary care providers with an interest in metabolic disease, diabetologists and endocrinologists in their daily clinical practice.
988			_aSpringer_Medicine_2020
650		7	_2embne _aMarcadores biológicos _9162047
700	1		_aRomero-Gomez, Manuel _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _1http://viaf.org/viaf/208086068
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783030371722
776	0	8	_iPrinted edition: _z9783030371746
776	0	8	_iPrinted edition: _z9783030371753
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-37173-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b06/2020 _dz _ea _zSI